Angela Rigopoulos

Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute

Affiliated withOlivia Newton-John Cancer Research Institute

Research Area

Biography

Angela Rigopoulos has not added Biography.
If you are Angela Rigopoulos and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title	2025

Other Publications

Article	Year
Integral membrane protease fibroblast activation protein sensitizes fibrosarcoma to chemotherapy and alters cell death mechanisms. Apoptosis : an international journal on programmed cell death\| PubMed ID: 26342814	2015
Molecular profiling of cetuximab and bevacizumab treatment of colorectal tumours reveals perturbations in metabolic and hypoxic response pathways. Oncotarget\| PubMed ID: 26517691	2015
Molecular Imaging and Quantitation of EphA2 Expression in Xenograft Models with 89Zr-DS-8895a. Journal of nuclear medicine : official publication, Society of Nuclear Medicine\| PubMed ID: 26940768	2016
Engineering anti-Lewis-Y hu3S193 antibodies with improved therapeutic ratio for radioimmunotherapy of epithelial cancers. EJNMMI research\| PubMed ID: 26983636	2016
Fluorine-18 radiolabeling of a nitrophenyl sulfoxide and its evaluation in an SK-RC-52 model of tumor hypoxia. Journal of labelled compounds & radiopharmaceuticals\| PubMed ID: 27435268	2016
L-Tyrosine Confers Residualizing Properties to a d-Amino Acid-Rich Residualizing Peptide for Radioiodination of Internalizing Antibodies. Molecular imaging\| PubMed ID: 27457521	2016
and Evaluation of Zr-DS-8273a as a Theranostic for Anti-Death Receptor 5 Therapy. Theranostics\| PubMed ID: 27924159	2016
Effect of Structural Modifications to Glyoxal-bis(thiosemicarbazonato)copper(II) Complexes on Cellular Copper Uptake, Copper-Mediated ATP7A Trafficking, and P-Glycoprotein Mediated Efflux. Journal of medicinal chemistry\| PubMed ID: 29232129	2018
Molecular imaging of T cell co-regulator factor B7-H3 with Zr-DS-5573a. Theranostics\| PubMed ID: 30128047	2018
Smac mimetics LCL161 and GDC-0152 inhibit osteosarcoma growth and metastasis in mice. BMC cancer\| PubMed ID: 31521127	2019
Deletion of intestinal Hdac3 remodels the lipidome of enterocytes and protects mice from diet-induced obesity. Nature communications\| PubMed ID: 31757939	2019
Synthesis and validation of [F]mBPET-1, a fluorine-18 labelled mTOR inhibitor derivative based on a benzofuran backbone. EJNMMI radiopharmacy and chemistry\| PubMed ID: 31974638	2020
Targeting and Efficacy of Novel mAb806-Antibody-Drug Conjugates in Malignant Mesothelioma. Pharmaceuticals (Basel, Switzerland)\| PubMed ID: 33023139	2020
Synthesis and fluorine-18 radiolabeling of a phospholipid as a PET imaging agent for prostate cancer. Nuclear medicine and biology\| PubMed ID: 33310350	2021
Radiolabelling and preclinical characterization of Zr-Df-radiolabelled bispecific anti-PD-L1/TGF-βRII fusion protein bintrafusp alfa. European journal of nuclear medicine and molecular imaging\| PubMed ID: 33608805	2021
Tumor volumes as a predictor of response to the anti-EGFR antibody drug conjugate depatuxizumab mafadotin. Neuro-oncology advances\| PubMed ID: 34549181	2021
F Site-Specific Labelling of a Single-Chain Antibody against Activated Platelets for the Detection of Acute Thrombosis in Positron Emission Tomography. International journal of molecular sciences\| PubMed ID: 35805892	2022
F-labeling and initial in vivo evaluation of a Hitomi peptide for imaging tissue transglutaminase 2. Nuclear medicine and biology\| PubMed ID: 36502585	2023
Bromodomain and extraterminal protein-targeted probe enables tumour visualisation using positron emission tomography. Chemical communications (Cambridge, England)\| PubMed ID: 36809538	2023
Automated radiosynthesis of [Zr]Zr-DFOSq-Durvalumab for imaging of PD-L1 expressing tumours in vivo. Nuclear medicine and biology\| PubMed ID: 37224789	2023
Preclinical radiolabeling, in vivo biodistribution and positron emission tomography of a novel pyrrolobenzodiazepine (PBD)-based antibody drug conjugate targeting ASCT2. Nuclear medicine and biology\| PubMed ID: 37473513	2023
Radiolabelling and preclinical characterisation of [Zr]Zr-Df-ATG-101 bispecific to PD-L1/4-1BB. European journal of nuclear medicine and molecular imaging\| PubMed ID: 38730087	2024
An Anti-VEGF-B Antibody Reduces Abnormal Tumor Vasculature and Enhances the Effects of Chemotherapy. Cancers\| PubMed ID: 38791979	2024
Targeting of immune checkpoint regulator V-domain Ig suppressor of T-cell activation (VISTA) with Zr-labelled CI-8993. European journal of nuclear medicine and molecular imaging\| PubMed ID: 39060374	2024
Targeting Fn14 as a therapeutic target for cachexia reprograms the glycolytic pathway in tumour and brain in mice. European journal of nuclear medicine and molecular imaging\| PubMed ID: 39060375	2024
Characterization of an Estrogen Receptor α-Selective F-Estradiol PET Tracer. World journal of nuclear medicine\| PubMed ID: 39170834	2024
Correction to: Targeting of immune checkpoint regulator V-domain Ig suppressor of T-cell activation (VISTA) with Zr-labelled CI-8993. European journal of nuclear medicine and molecular imaging\| PubMed ID: 39186103	2024
DNA-Dependent Protein Kinase Inhibitor Peposertib Enhances Efficacy of Lu-Based Radioimmunotherapy in Preclinical Models of Prostate and Renal Cell Carcinoma. Journal of nuclear medicine : official publication, Society of Nuclear Medicine\| PubMed ID: 39884775	2025